| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 1947 | 2018 |
| CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation–a target for novel cancer therapy R Tokunaga, WU Zhang, M Naseem, A Puccini, MD Berger, S Soni, ... Cancer treatment reviews 63, 40-47, 2018 | 1174 | 2018 |
| Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study E Domingo, L Freeman-Mills, E Rayner, M Glaire, S Briggs, L Vermeulen, ... The lancet Gastroenterology & hepatology 1 (3), 207-216, 2016 | 313 | 2016 |
| Tumour budding in solid cancers A Lugli, I Zlobec, MD Berger, R Kirsch, ID Nagtegaal Nature Reviews Clinical Oncology 18 (2), 101-115, 2021 | 263 | 2021 |
| Outlooks on Epstein-Barr virus associated gastric cancer M Naseem, A Barzi, C Brezden-Masley, A Puccini, MD Berger, ... Cancer treatment reviews 66, 15-22, 2018 | 222 | 2018 |
| B cell and B cell-related pathways for novel cancer treatments R Tokunaga, M Naseem, JH Lo, F Battaglin, S Soni, A Puccini, MD Berger, ... Cancer treatment reviews 73, 10-19, 2019 | 190 | 2019 |
| Multicenter international society for immunotherapy of cancer study of the consensus immunoscore for the prediction of survival and response to chemotherapy in stage III colon … B Mlecnik, C Bifulco, G Bindea, F Marliot, A Lugli, JJ Lee, I Zlobec, TT Rau, ... Journal of clinical oncology 38 (31), 3638-3651, 2020 | 175 | 2020 |
| Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study VH Koelzer, I Zlobec, MD Berger, G Cathomas, H Dawson, K Dirschmid, ... Virchows Archiv 466, 485-493, 2015 | 135 | 2015 |
| Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy … MD Berger, B Gerber, K Arn, O Senn, U Schanz, G Stussi Haematologica 97 (1), 116, 2012 | 115 | 2012 |
| Stromal PD-1/PD-L1 expression predicts outcome in colon cancer patients J Wyss, B Dislich, VH Koelzer, JA Galván, H Dawson, M Hädrich, ... Clinical colorectal cancer 18 (1), e20-e38, 2019 | 88 | 2019 |
| Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer R Tokunaga, J Xiu, C Johnston, RM Goldberg, PA Philip, A Seeber, ... Clinical Cancer Research 25 (10), 3096-3103, 2019 | 86 | 2019 |
| TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer JA Galván, M Helbling, VH Koelzer, MP Tschan, MD Berger, M Hädrich, ... Oncotarget 6 (2), 874, 2014 | 85 | 2014 |
| Comprehensive genomic profiling of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) A Puccini, K Poorman, ME Salem, D Soldato, A Seeber, RM Goldberg, ... Clinical Cancer Research 26 (22), 5943-5951, 2020 | 84 | 2020 |
| Colorectal cancer: epigenetic alterations and their clinical implications A Puccini, MD Berger, M Naseem, R Tokunaga, F Battaglin, S Cao, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1868 (2), 439-448, 2017 | 81 | 2017 |
| CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival VH Koelzer, A Lugli, H Dawson, M Hädrich, MD Berger, M Borner, ... Journal of translational medicine 12, 1-11, 2014 | 76 | 2014 |
| Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer H Dawson, F Galuppini, P Träger, MD Berger, P Studer, L Brügger, ... Human pathology 85, 145-151, 2019 | 75 | 2019 |
| Tumour budding and its clinical implications in gastrointestinal cancers I Zlobec, MD Berger, A Lugli British journal of cancer 123 (5), 700-708, 2020 | 64 | 2020 |
| CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway J Graule, K Uth, E Fischer, I Centeno, JA Galván, M Eichmann, TT Rau, ... Clinical epigenetics 10, 1-12, 2018 | 61 | 2018 |
| Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer G Rieger, VH Koelzer, HE Dawson, MD Berger, M Hädrich, D Inderbitzin, ... Histopathology 70 (7), 1044-1051, 2017 | 56 | 2017 |
| Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients Y Ning, W Zhang, DL Hanna, D Yang, S Okazaki, MD Berger, Y Miyamoto, ... The pharmacogenomics journal 18 (1), 29-34, 2018 | 53 | 2018 |
Heinz-Josef LenzUniversity of Southern Califfornia在 usc.edu 的电子邮件经过验证
